ClinConnect ClinConnect Logo
Search / Trial NCT06040281

Smart and Fit for Kidney Transplantation

Launched by UNIVERSITY OF ERLANGEN-NÜRNBERG MEDICAL SCHOOL · Sep 8, 2023

Trial Information

Current as of June 27, 2025

Recruiting

Keywords

Transplantation Prehabilitation Exercise And Nutritional Support

ClinConnect Summary

The "Smart and Fit for Kidney Transplantation" trial is designed to help patients with chronic kidney disease who are waiting for a kidney transplant. The study will include 200 participants who are currently on dialysis. Researchers want to see if providing personalized nutritional advice and exercise support, along with a complete rehabilitation program, will improve health outcomes compared to a group that does not receive this support.

To participate, patients must be at least 18 years old, own a smartphone, and be willing to take part in rehabilitation during the study. They should also be physically and mentally able to engage in exercise and nutritional counseling. If you join the study, you can expect personalized guidance to help prepare for your transplant. This trial is actively recruiting participants, so if you think it could be a good fit for you or a loved one, consider reaching out for more information!

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients must be on dialysis
  • Patients ≥ 18 years of age
  • Patients who own a smartphone
  • Patients must be willing to undergo inpatient rehabilitation within the project period
  • signed informed consent and data protection regulation
  • Exclusion Criteria:
  • Patients who are not psychologically or physically able to take part in exercise promotion measures and/or nutritional counselling as well as psychological offers
  • Patients who have already participated in a similar project

About University Of Erlangen Nürnberg Medical School

The University of Erlangen-Nürnberg Medical School is a prestigious institution dedicated to advancing medical research and improving healthcare outcomes through innovative clinical trials. Renowned for its interdisciplinary approach, the medical school fosters collaboration among experts in various fields, enabling the development of cutting-edge therapies and treatment protocols. With a commitment to ethical standards and patient safety, the institution actively contributes to the global medical community by conducting rigorous clinical studies aimed at enhancing the understanding and management of diverse health conditions.

Locations

Erlangen, Bavaria, Germany

Patients applied

0 patients applied

Trial Officials

Mario Schiffer, Prof.

Study Director

Universitätsklinikum Erlangen

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported